Developing Novel, Supercharged Immunotherapies for Cancer and Immune Disorders
The Immunotherapy stream highlights the most exciting technologies, tools and engineering strategies driving the development of cellular and non-cellular immunotherapies for cancer and immune disorders. Part One examines recent breakthroughs in immunotherapy
efficacy and safety across a range of modalities; Part Two focuses on the latest innovations and efforts to improve cell-based immunotherapies such as CAR T and NK cell therapies; with Part Three focusing on developing the next generation of immunotherapies
, including reprogramming the immune system, immune cell engineering, in vivo, gene and vector editing and delivery, all supported by in-depth case studies, novel engineering approaches and clinical data.
Improving Immunotherapy Efficacy and Safety
Next Generation Immunotherapies